Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Buy
92
BPXXY Quote, Financials, Valuation and Earnings
Last price:
$18.00
Seasonality move
:
5.83%
Day range:
$18.00 - $18.00
52-week range:
$8.37 - $19.91
Dividend yield:
7.54%
P/E ratio:
8.71x
P/S ratio:
2.08x
P/B ratio:
1.00x
Volume:
--
Avg. volume:
33
1-year change:
115.05%
Market cap:
$12.7B
Revenue:
$6.5B
EPS (TTM):
$2.07
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1B | $4.4B | $4.5B | $6.4B | $6.5B | |
| Revenue Growth (YoY) | 11.91% | 40.22% | 3.84% | 39.8% | 1.9% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $582.5M | $801M | $963M | $884.3M | $835.5M | |
| Other Inc / (Exp) | $25.7M | $53.4M | $17.6M | -$128.1M | -$141.8M | |
| Operating Expenses | $2.2B | $3.1B | $3.4B | $3.6B | $3.6B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $224.7M | $819.8M | $1.5B | $1.9B | $2.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$74.4M | $158.8M | -$90.5M | $187.2M | $666.2M | |
| Net Income to Company | $270.6M | $621.3M | $1.5B | $1.6B | $1.5B | |
| Minority Interest in Earnings | -$28.6M | -$39.7M | -$26.3M | -$34.9M | -$38.8M | |
| Net Income to Common Excl Extra Items | $270.6M | $621.3M | $1.5B | $1.6B | $1.5B | |
| Basic EPS (Cont. Ops) | $0.80 | $0.88 | $2.16 | $2.33 | $2.15 | |
| Diluted EPS (Cont. Ops) | $0.75 | $0.86 | $2.10 | $2.27 | $2.10 | |
| Weighted Average Basic Share | $339.5M | $706.2M | $706M | $707.4M | $707.8M | |
| Weighted Average Diluted Share | $357.4M | $724M | $723.8M | $725.2M | $724.5M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $444.2M | $1.1B | $1.9B | $3.5B | $4B | |
| Revenue (Reported) | $3.1B | $4.4B | $4.5B | $6.4B | $6.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $444.2M | $1.1B | $1.9B | $3.5B | $4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $1.1B | $1.5B | $1.6B | $1.6B | |
| Revenue Growth (YoY) | 40.73% | 7.41% | 38.04% | 7.63% | 0.12% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $213.8M | $194.5M | $356.9M | $170M | $153.4M | |
| Other Inc / (Exp) | $16.3M | $23.8M | $1.2M | -$13.1M | -$55.8M | |
| Operating Expenses | $817.9M | $760.8M | $929.4M | $994.3M | $806M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $659.9M | $177.6M | $416.3M | $664M | $709M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $169.7M | $44.4M | $94.8M | $157.5M | $234M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$7.9M | -$6.8M | -$9.3M | -$9.7M | -$9M | |
| Net Income to Common Excl Extra Items | $482.3M | $126.4M | $312.2M | $496.7M | $466.1M | |
| Basic EPS (Cont. Ops) | $0.68 | $0.18 | $0.44 | $0.70 | $0.66 | |
| Diluted EPS (Cont. Ops) | $0.67 | $0.18 | $0.44 | $0.68 | $0.64 | |
| Weighted Average Basic Share | $707.2M | $704.2M | $707.1M | $707.9M | $707.5M | |
| Weighted Average Diluted Share | $725.1M | $722.3M | $707.1M | $725.8M | $723.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $725.8M | $247.7M | $767.2M | $1.1B | $1B | |
| Revenue (Reported) | $1B | $1.1B | $1.5B | $1.6B | $1.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $725.8M | $247.7M | $767.2M | $1.1B | $1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $4.4B | $5.1B | $6.3B | $6.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $657.7M | $811.8M | $1.2B | $747.2M | $742M | |
| Other Inc / (Exp) | $77M | $66.6M | $18.7M | -$86.8M | -$274.8M | |
| Operating Expenses | $2.4B | $3.4B | $3.7B | $3.9B | $3.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $868.7M | $358.3M | $1.7B | $2.1B | $2.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $90.8M | $41.2M | -$28M | $251.9M | $743.9M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$31.7M | -$38.6M | -$28.7M | -$35.3M | -$38.1M | |
| Net Income to Common Excl Extra Items | $746.2M | $278.5M | $1.7B | $1.8B | $1.5B | |
| Basic EPS (Cont. Ops) | $1.29 | $0.40 | $2.45 | $2.59 | $2.11 | |
| Diluted EPS (Cont. Ops) | $1.27 | $0.38 | $2.40 | $2.56 | $2.07 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1B | $590.1M | $2.3B | $3.4B | $3.5B | |
| Revenue (Reported) | $3.3B | $4.4B | $5.1B | $6.3B | $6.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1B | $590.1M | $2.3B | $3.4B | $3.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $1.1B | $1.5B | $1.6B | $1.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $213.8M | $194.5M | $356.9M | $170M | $153.4M | |
| Other Inc / (Exp) | $16.3M | $23.8M | $1.2M | -$13.1M | -$55.8M | |
| Operating Expenses | $817.9M | $760.8M | $929.4M | $994.3M | $806M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $659.9M | $177.6M | $416.3M | $664M | $709M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $169.7M | $44.4M | $94.8M | $157.5M | $234M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$7.9M | -$6.8M | -$9.3M | -$9.7M | -$9M | |
| Net Income to Common Excl Extra Items | $482.3M | $126.4M | $312.2M | $496.7M | $466.1M | |
| Basic EPS (Cont. Ops) | $0.68 | $0.18 | $0.44 | $0.70 | $0.66 | |
| Diluted EPS (Cont. Ops) | $0.67 | $0.18 | $0.44 | $0.68 | $0.64 | |
| Weighted Average Basic Share | $707.2M | $704.2M | $707.1M | $707.9M | $707.5M | |
| Weighted Average Diluted Share | $725.1M | $722.3M | $707.1M | $725.8M | $723.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $725.8M | $247.7M | $767.2M | $1.1B | $1B | |
| Revenue (Reported) | $1B | $1.1B | $1.5B | $1.6B | $1.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $725.8M | $247.7M | $767.2M | $1.1B | $1B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.5B | $24.7B | $16.6B | $12.4B | $9.4B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $12B | $25.7B | $19.7B | $14.8B | $11.1B | |
| Property Plant And Equipment | $1.3B | $1.9B | $2.2B | $2.2B | $2.1B | |
| Long-Term Investments | $30.8B | $32.7B | $35.5B | $33.5B | $31.4B | |
| Goodwill | $534.7M | $231.4M | $219.2M | $187.9M | $176.9M | |
| Other Intangibles | $329.6M | $288.5M | $385.1M | $529.4M | $562.7M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $114.5B | $154.4B | $163.3B | $157.1B | $146.3B | |
| Accounts Payable | $1B | $1.2B | $2.5B | $2B | $1.6B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.4B | $2.9B | $6.4B | $6B | $3.9B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $106.7B | $146.6B | $154.6B | $146.5B | $134.3B | |
| Common Stock | $2.6B | $2.4B | $2.3B | $2.3B | $2.2B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $7.6B | $7.6B | $8.5B | $10.4B | $11.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $164.8M | $184M | $193.4M | $220.3M | $218.9M | |
| Total Equity | $7.8B | $7.8B | $8.7B | $10.6B | $12B | |
| Total Liabilities and Equity | $114.5B | $154.4B | $163.3B | $157.1B | $146.3B | |
| Cash and Short Terms | $11.5B | $24.7B | $16.6B | $12.4B | $9.4B | |
| Total Debt | $8.8B | $8.3B | $10.8B | $19.9B | $20.7B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $23B | $23.7B | $18.7B | $11.8B | $9.3B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $23.9B | $25.4B | $23.6B | $12.8B | $11B | |
| Property Plant And Equipment | $2.2B | $2.2B | $2.7B | $2.8B | $2.7B | |
| Long-Term Investments | $31.4B | $32.1B | $35.8B | $30.1B | $34.3B | |
| Goodwill | $239.6M | $228.1M | $222.9M | $183.6M | $184M | |
| Other Intangibles | $306.5M | $289.7M | $387.3M | $530.3M | $576.5M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $151.2B | $151.6B | $164.8B | $151.3B | $153.6B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.3B | $1.8B | $3.3B | -- | $2.1B | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $143.2B | $143.9B | $155.6B | $139.9B | $140.7B | |
| Common Stock | $2.5B | $2.3B | $2.3B | $2.3B | $2.3B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $164.9M | $188.4M | $205.1M | $224.9M | $237.4M | |
| Total Equity | $8B | $7.7B | $9.2B | $11.4B | $13B | |
| Total Liabilities and Equity | $151.2B | $151.6B | $164.8B | $151.3B | $153.6B | |
| Cash and Short Terms | $23B | $23.7B | $18.7B | $11.8B | $9.3B | |
| Total Debt | $9.1B | $8.4B | $10.8B | $13.1B | $21.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $270.6M | $621.3M | $1.5B | $1.6B | $1.5B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$731.9M | $1.5B | $13.5B | -$3.7B | -$2.7B | |
| Capital Expenditures | $269.3M | $291.3M | $352.9M | $413M | $387.6M | |
| Cash Acquisitions | -$9.1M | -$617.6M | $291M | -$4.2M | $114.9M | |
| Cash From Investing | -$254.8M | -$879.3M | -$18M | -$340M | -$233M | |
| Dividends Paid (Ex Special Dividend) | -$3.7M | -$72.3M | -$96.3M | -$196M | -$484.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$3.6M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | $1.1B | |
| Cash From Financing | $882.7M | -$75.9M | -$90.2M | -$193.1M | $555.6M | |
| Beginning Cash (CF) | $1.1B | $1B | $1.4B | $15.2B | $10.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$104M | $541.5M | $13.4B | -$4.2B | -$2.4B | |
| Ending Cash (CF) | $969.7M | $1.5B | $14.8B | $10.9B | $8.5B | |
| Levered Free Cash Flow | -$1B | $1.2B | $13.1B | -$4.1B | -$3.1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | $39.4M | $132.4M | $58.1M | $75.2M | $128.8M | |
| Cash Acquisitions | -- | -$627.1M | $293.8M | -$3.1M | $114.1M | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -$3.5M | -$73.6M | -$97.2M | -$197.4M | -$483.2M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get BPXXY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BPXXY
Sector
P/E ratio
8.71x
--
PEG ratio
0.14x
--
P/B ratio
1.00x
--
Price / LTM sales
2.08x
--
Growth Metrics
BPXXY
Sector
Revenue growth
0.12%
--
Earnings growth
-5.9%
--
Revenue (5-year growth)
18.34%
--
Earnings forecast
--
--
Profitability
BPXXY
Sector
Profitability FY 2025
--
--
Return on invested capital
4.76%
--
Return on assets
0.99%
--
Return on equity
12.52%
--
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
13
Estimated Next Earnings Date
Aug
7
Balance Sheet
BPXXY
Sector
Total cash
$9.3B
--
Short term investments
--
--
Total assets
$146.3B
--
Long term debt
$21.5B
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
